Answers are grounded in this paper and cite their sources.
Randomized controlled trial compares glycemic control in pregnancy with low-dose and high-dose vitamin D, indicating higher doses might be more effective.
Introduction: Gestational diabetes mellitus (GDM) is a prevalent pregnancy-related metabolic disorder that contributes to significant maternal and neonatal complications. The role of vitamin D in improving glycemic regulation has been well researched, but appropriate dosing strategy remains uncertain. Objective: To compare the effects of low-dose versus high-dose vitamin D supplementation on fasting blood sugar (FBS) and insulin resistance (HOMA-IR) in pregnant women diagnosed with GDM. Methods: This randomized controlled trial was carried out at Sir Ganga Ram Hospital, Lahore, from 1st January 2025 to 31st May 2025. A total of 300 pregnant women with GDM (gestational age 24–37 weeks) were randomized into two groups. Group A was given vitamin D (2,500 IU every two weeks), whereas Group B received vitamin D (50,000 IU every two weeks). FBS and HOMA-IR were measured at baseline, after 15 days, and at one month. Data analysis was performed using SPSS v25. Results: After one month of supplementation, the mean FBS levels dropped to 112.6 ± 10.4 mg/dl in the Group A and to 98.8 ± 9.8 mg/dl in the Group B (p < 0.001). Similarly, mean HOMA-IR decreased to 3.88 ± 0.9 in Group A and 2.95 ± 0.8 in Group B (p < 0.001). Conclusion: High-dose vitamin D supplementation was more effective than low-dose therapy in improving glycemic parameters among women with GDM. Hence, higher vitamin D regimens may be beneficial as adjunctive therapy to optimize metabolic control in this population.
No takes yet. Share an insight, caveat, or question.
Hussain et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: